There was a time when Lance Armstrong was more than just a cyclist. He was a global phenomenon, an emblem of human resilience, and a sports icon who seemingly transcended the limits of physical capability.
From 1999 to 2005, Armstrong ruled the grueling mountain peaks and time trials of the Tour de France, capturing an unprecedented seven consecutive yellow jerseys.
As the undisputed leader of the US Postal Service Pro Cycling Team, his story was a Hollywood script come to life: a young athlete who conquered advanced testicular cancer, returned to the bike, and completely re-engineered how the sport was raced.
Beyond the asphalt, his success fueled Livestrong, a commercial and charitable powerhouse symbolized by millions of ubiquitous yellow silicone wristbands. Armstrong wasn’t just winning races; he was leading a global movement against cancer.
But the empire was built on a foundation of systemic deception.
The turning point came after years of fierce denials, aggressive lawsuits against whistleblowers, and intense federal investigations. In an explosive public confession, Armstrong finally admitted to what investigators called the most sophisticated doping program in sports history.
He detailed his extensive use of performance-enhancing drugs (PEDs) — including erythropoietin (EPO), blood transfusions, and testosterone — to artificially boost his endurance, particularly during the brutal alpine and Pyrenean mountain climbs that defined his career.
The fallout was swift, total, and permanent. The Union Cycliste Internationale (UCI) acted on a damning report from the US Anti-Doping Agency (USADA), effectively erasing Armstrong from the history books.